In the management of chronic respiratory diseases, precision and dual-action therapy are often the keys to maintaining a high quality of life. IPRATROP LD RESPULES, featuring the powerful combination of Levosalbutamol and Ipratropium Bromide Respirator Solution, is a clinically trusted medication designed to provide rapid and sustained relief from obstructive airway symptoms. Whether you are dealing with a sudden flare-up or managing a long-term condition, understanding how this combination works is essential for effective treatment.
IPRATROP LD RESPULES is a specialized inhalation solution used primarily in nebulization therapy. It combines two different classes of bronchodilators: Levosalbutamol (a selective beta-2 agonist) and Ipratropium Bromide (an anticholinergic). The "LD" in the name typically signifies "Low Dose," making it a refined choice for patients who require effective bronchodilation with a minimized risk of systemic side effects.
Unlike standard inhalers, these respules are designed for use with a nebulizer, which converts the liquid medicine into a fine mist. This delivery method is particularly beneficial for children, elderly patients, or individuals experiencing severe respiratory distress who may find it difficult to coordinate their breathing with a traditional pressurized inhaler.
The primary objective of Levosalbutamol and Ipratropium Bromide Respirator Solution is to open the airways and improve airflow to the lungs. It is widely prescribed for
Chronic Obstructive Pulmonary Disease (COPD): This includes chronic bronchitis and emphysema, where the airways are often narrow and obstructed.
Asthma Management: It is highly effective for treating acute asthma symptoms and preventing the worsening of breathing difficulties.
Bronchospasm: It provides quick relief from the tightening of the muscles around the airways caused by allergens, pollutants, or exercise.
Wheezing and Chest Tightness: By relaxing the bronchial muscles, it helps eliminate the whistling sound (wheezing) and the feeling of pressure in the chest.
The synergy between Levosalbutamol and Ipratropium Bromide offers several advantages over single-agent therapies:
Complementary Mechanisms: Levosalbutamol works by stimulating receptors to relax the airway muscles, while Ipratropium Bromide blocks the signals that cause those muscles to contract. Together, they provide a more comprehensive "opening" of the lungs.
Rapid & Prolonged Relief: Levosalbutamol provides a quick onset of action (often within minutes), while Ipratropium Bromide ensures the bronchodilation lasts for a longer duration, keeping the airways open for several hours.
Deeper Lung Penetration: Use through a nebulizer ensures that the medication reaches the smaller, deeper passages of the lungs, which is crucial during severe episodes of breathlessness.
Reduced Mucus Production: Ipratropium Bromide also helps in reducing the secretion of excess mucus, further clearing the path for easier breathing.
The dosage of IPRATROP LD RESPULES must be tailored by a healthcare provider based on the patient's clinical condition and age.
Standard Administration: One respule (usually 2.5ml) is typically administered three to four times a day via a nebulizer.
How to Use: Twist open the respule and squeeze the entire contents into the nebulizer chamber. Breathe in the mist slowly and deeply until the solution is completely used up (usually 5 to 10 minutes).
Consistency: For maintenance therapy, it is best to take the doses at regularly spaced intervals to maintain consistent airway patency.
While generally safe, some patients may experience mild side effects. These are usually temporary and occur as the body adjusts to the medication:
Dry mouth or throat irritation.
Mild headache or dizziness.
Nervousness or slight tremors.
Nausea or stomach upset.
Coughing immediately after inhalation.
If you experience more serious symptoms, such as a rapid heartbeat, chest pain, or blurred vision, consult your doctor immediately.
To ensure safety, keep the following precautions in mind:
Medical History: Inform your doctor if you have a history of heart disease, high blood pressure, seizures, or thyroid issues.
Glaucoma & Urinary Issues: Because Ipratropium is an anticholinergic, it should be used with caution in patients with narrow-angle glaucoma or an enlarged prostate, as it can worsen these conditions.
Eye Protection: Ensure the nebulizer mask fits well; getting the mist in your eyes can cause temporary blurred vision or eye pain.
Pregnancy: Consult your physician if you are pregnant or breastfeeding, as the benefits must be weighed against potential risks.
Equipment Hygiene: Always clean your nebulizer after use to prevent bacterial growth and ensure the device delivers the correct dose every time.
IPRATROP LD RESPULES (Levosalbutamol and Ipratropium Bromide Respirator Solution) is a cornerstone treatment for individuals battling obstructive lung diseases. By targeting the airways through two distinct pathways, it ensures that patients can breathe more freely and return to their daily activities with confidence. Always use this medication under the strict guidance of a medical professional to achieve the best therapeutic results.



Price:
Price 1034.0 INR / Unit
Minimum Order Quantity : 1 Unit
Suitable For : Adults
Origin of Medicine : AS directed by the physician
Drug Type : General Medicines
Pacakaging (Quantity Per Box) : 10*5*2ml
Price 20.0 INR / Piece
Minimum Order Quantity : 10 Units
Suitable For : Adults
Origin of Medicine : INDIA
Drug Type : Organic Medicine
Pacakaging (Quantity Per Box) : 10x5x2.5ml
Price 215 INR / Piece
Minimum Order Quantity : 1 Piece
Suitable For : Adults
Origin of Medicine : India
Drug Type : General Medicines
Pacakaging (Quantity Per Box) : 30 Capsules
Price 1312.5 INR / Unit
Minimum Order Quantity : 1 Unit
Suitable For : Adults
Origin of Medicine : india
Drug Type : General Medicines
Pacakaging (Quantity Per Box) : 10x5x2 ml